Cargando…
Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm
The neurotropic rabies virus (RABV) is a prototype member of the Mononegavirales order of viruses and is the most significant human pathogen of the Rhabdoviridae family. A reverse genetics system for RABV was established almost 20 years ago, providing a paradigm for other Mononegavirales members as...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121350/ http://dx.doi.org/10.1007/978-4-431-54556-9_1 |
_version_ | 1783515182788509696 |
---|---|
author | Conzelmann, Karl-Klaus |
author_facet | Conzelmann, Karl-Klaus |
author_sort | Conzelmann, Karl-Klaus |
collection | PubMed |
description | The neurotropic rabies virus (RABV) is a prototype member of the Mononegavirales order of viruses and is the most significant human pathogen of the Rhabdoviridae family. A reverse genetics system for RABV was established almost 20 years ago, providing a paradigm for other Mononegavirales members as well. The availability of engineered recombinant viruses opened a new era to study common aspects of Mononegavirales biology and specific aspects of the unique lifestyle and pathogenesis of individual members. Above all, the knowledge gained has allowed engineering of beneficial biomedical tools such as viral vectors, vaccines, and tracers. In this chapter, the development of the classical rabies virus reverse genetics approach is described, and some of the most exciting biomedical applications for recombinant RABV and other Mononegavirales are briefly addressed. |
format | Online Article Text |
id | pubmed-7121350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71213502020-04-06 Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm Conzelmann, Karl-Klaus Sendai Virus Vector Article The neurotropic rabies virus (RABV) is a prototype member of the Mononegavirales order of viruses and is the most significant human pathogen of the Rhabdoviridae family. A reverse genetics system for RABV was established almost 20 years ago, providing a paradigm for other Mononegavirales members as well. The availability of engineered recombinant viruses opened a new era to study common aspects of Mononegavirales biology and specific aspects of the unique lifestyle and pathogenesis of individual members. Above all, the knowledge gained has allowed engineering of beneficial biomedical tools such as viral vectors, vaccines, and tracers. In this chapter, the development of the classical rabies virus reverse genetics approach is described, and some of the most exciting biomedical applications for recombinant RABV and other Mononegavirales are briefly addressed. 2013-11-21 /pmc/articles/PMC7121350/ http://dx.doi.org/10.1007/978-4-431-54556-9_1 Text en © Springer Japan 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Conzelmann, Karl-Klaus Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm |
title | Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm |
title_full | Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm |
title_fullStr | Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm |
title_full_unstemmed | Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm |
title_short | Reverse Genetics of Mononegavirales: The Rabies Virus Paradigm |
title_sort | reverse genetics of mononegavirales: the rabies virus paradigm |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121350/ http://dx.doi.org/10.1007/978-4-431-54556-9_1 |
work_keys_str_mv | AT conzelmannkarlklaus reversegeneticsofmononegaviralestherabiesvirusparadigm |